Dr. Getz's research is focused on the treatment and supportive care of children and young adults with cancer, and on understanding and balancing the associated therapeutic benefits and toxicity risks, with an emphasis in cardio-oncology. Her overarching research goal is to develop and apply advanced epidemiologic methods to existing data resources in creative ways to enable observational research studies that will impact practice. She hopes that her research will address treatment and outcome disparities, and improve both clinical outcomes and quality of life for pediatric cancer patients across diagnoses, during treatment, and into survivorship.

Her Alex's Lemonade Stand Foundation Young Investigator Award evaluates risk factors for cardiac dysfunction during AML therapy and assesses novel early indicators of cardiotoxicity to identify patients at the highest risk before they progress to overt irreversible cardiomyopathy.

Her NHLBI K01 leverages the strengths of multiple complementary data resources including the clinical trial data, administrative billing data, echocardiographic studies, and large volume electronic health record data to address important questions across the cardiotoxicity risk continuum.

MPH, Boston University (Epidemiology), 2009

PhD, Boston University (Epidemiology), 2014

Postdoctoral Fellow, Children's Hospital of Philadelphia(Pediatric Cancer Epidemiology), 2014-2016

Assistant Professor of Epidemiology

Research Scientist

Society for Epidemiologic Research, 2010-

Society for Pediatric and Perinatal Epidemiologic Research, 2009-

American Society of Clinical Oncology, 2014-

Children's Oncology Group , 2014-

GlaxoSmithKline R&D Award for Pharmacodynamic Modeling and Simulation, 2003

Lilly Champion Award for Expertise in Population Pharmacokinetic Modeling, 2004

Boston University Reproductive, Perinatal, and Pediatric Epidemiology Training Program (T32 HD052458), 2009-2013

NIH, NICHD, and CIHR Joint Summer Institute in Reproductive and Perinatal Epidemiology, 2012

Society of Epidemiologic Research First Prize Methods Abstract, 2014

Heart House Roundtable, Cardio-Oncology: Risk Assessment & Management Strategies, 2019

Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia

• Alex's Lemonade Stand Foundation Young Investigator Award
• 2018-2020
• PI: Getz

Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia: an Assessment of Development, Progression, and Mitigation

• NIH K01-HL143153
• 2018-2023
• PI: Getz

Profile at PSOM

Profile at CCEB